Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 019059

Expand all

INDERIDE LA 120/50 (HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE)
50MG;120MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Proprietary Name: INDERIDE LA 120/50
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 50MG;120MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019059
Product Number: 002
Approval Date: Jul 3, 1985
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

INDERIDE LA 160/50 (HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE)
50MG;160MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Proprietary Name: INDERIDE LA 160/50
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 50MG;160MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019059
Product Number: 003
Approval Date: Jul 3, 1985
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

INDERIDE LA 80/50 (HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE)
50MG;80MG
Marketing Status: Discontinued

Active Ingredient: HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Proprietary Name: INDERIDE LA 80/50
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 50MG;80MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N019059
Product Number: 001
Approval Date: Jul 3, 1985
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information